MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2023 International Congress

    A Parkinson Shoe with Combined Plantar Pressure and Vibratory Stimulation in Parkinson’s Disease Patients with Freezing of Gait: A Randomized Controlled Trial with Plantar Pressure Analysis

    W. Phuenpathom, P. Panyakaew, P. Vateekul, D. Surangsrirat, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of PD shoes on plantar pressure in PD patients with FOG. Background: Dysfunction of peripheral sensory systems, including decreased cutaneous mechanoreceptors…
  • 2023 International Congress

    Can a single-session of weight-shift training support people with Parkinson’s step from a freeze?

    Y. Russo, P. Leveridge, J. Ye, Z. Wang, M. Wilson, A. Nieuwboer, S. Lamb, E. Kal, M. Norris, W. Young (Exeter, United Kingdom)

    Objective: To assess the efficacy and the safety of a weight-shift (WS) intervention used in a complex and demanding gait context Background: Freezing of gait…
  • 2023 International Congress

    Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis

    M. Pinter, M. Petrovicsova, Y. Teuschl, A. Dachenhausen, K. Matz, C. Bancher (Krems, Austria)

    Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…
  • 2023 International Congress

    The Effects of Consecutive and Integrated Postural-Cognitive Training on Dual-task Walking in Parkinson’s Disease with Mild Cognitive Impairment: EEG Relative Power and Clinical Implication

    YA. Chen, CY. Huang, RM. Wu, CL. Chang (Taipei, Taiwan)

    Objective: The purpose of this study was to compare the effects of consecutive and integrated postural-cognitive training on dual-task walking performance and its related cortical…
  • 2023 International Congress

    Online education to promote compensation strategies for gait impairments in underserved Parkinson populations

    T. Capato, A. Tosserams, B. Bloem, J. Nonnekes (São Paulo, Brazil)

    Objective: Here, we explore the potential health benefits of using an online educational platform about compensation strategies for gait impairment in Parkinson’s disease (PD), in…
  • 2023 International Congress

    Hydrocephalus associated with Chiari-I malformation presenting with parkinsonism and dystonia

    A. Maheshwary, L. Wolansky, B. Rodrigues, K. Bulsara, D. Karimeddini, B. Springate, N. Prakash (Hartford, USA)

    Objective: To provide a case description of dystonia-predominant parkinsonism due to underlying hydrocephalus associated with CIM in an adult. Background: Hydrocephalus is estimated to be…
  • 2023 International Congress

    Effects of a rhythmic auditory stimulation-enhanced walking program on Veterans with Parkinson’s disease with and without subthalamic nucleus deep brain stimulation.

    A. Umbarger, S. Kletzel, S. Walker, C. Jelinek, C. Kestner, K. Krese, B. Mcreavy, T. Bender Pape, F. Weaver, K. Colletta (Gary, USA)

    Objective: Describe outcomes from a 12-week home-based rhythmic auditory stimulation (RAS)-enhanced walking program completed by Veterans with Parkinson’s disease (PD); 1 with subthalamic nucleus deep brain stimulation…
  • 2022 International Congress

    Alprazolam reduces freezing of gait and improves freezing-related gait measures

    A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • 2022 International Congress

    Relationship between gait speed and functional measurements in Parkinson’s disease

    D. Iucksch, B. Yamaguchi, L. Araujo, V. Israel (CURITIBA, Brazil)

    Objective: The present study aims to relate gait speed in Parkinson's disease (PD) with functional measures of muscle strength, balance and physical capacity. Background: PD…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley